Skip to main content

Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cells

Collis, S.J, Tighe, A., Scott, Simon D., Roberts, S.A, Hendry, J.H, Margison, G.P (2001) Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cells. Nucleic Acids Research, 29 (7). pp. 1534-1538. ISSN 0305-1048. (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:8420)

The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided.

Abstract

The strand transferase RAD51 is a component of the homologous recombination repair pathway. To examine the contribution of RAD51 to the genotoxic effects of ionising radiation, we have used a novel ribozyme strategy. A reporter gene vector was constructed so that expression of an inserted synthetic double-stranded ribozyme-encoding oligonucleotide would be under the control of the cytomegalovirus immediate-early gene enhancer/promoter system, The prostate tumour cell line LNCaP was transfected with this vector or a control vector, and a neomycin resistance gene on the vector was used to create geneticin-resistant stable cell lines. Three stable cell lines were shown by western blot analysis to have significant down-regulation of RAD51 to 20-50% of the levels expressed in control cell lines. All three cell lines had a similar increased sensitivity to gamma -irradiation by 70 and 40%, respectively, compared to normal and empty vector-transfected cells, corresponding to dose-modifying factors of similar to2.0 and 1.5 in the mid-range of the dose-response curves. The amount of RAD51 protein in transfected cell lines was shown to strongly correlate with the alpha parameter obtained from fitted survival curves. These results highlight the importance of RAD51 in cellular responses to radiation and are the first to indicate the potential use of RAD51-targeted ribozyme minigenes in tumour radiosensitisation.

Item Type: Article
Subjects: Q Science > Q Science (General)
Divisions: Divisions > Division of Natural Sciences > Medway School of Pharmacy
Depositing User: Simon Scott
Date Deposited: 09 Oct 2008 14:20 UTC
Last Modified: 16 Nov 2021 09:46 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/8420 (The current URI for this page, for reference purposes)

University of Kent Author Information

  • Depositors only (login required):

Total unique views for this document in KAR since July 2020. For more details click on the image.